Candidiasis Therapeutics Market

Future Market Insights

Key Insight

The candidiasis therapeutics market is projected to grow from USD 3.4 billion in 2025 to USD 4.7 billion by 2035, at a CAGR of 3.3%. Oral will dominate with a 57.3% market share, while azole will lead the class of drugs segment with a 41.2% share.

September 12, 2025

Anurag Sharma

250 Pages

Cite this Report

Candidiasis Therapeutics Market

https://www.futuremarketinsights.com/reports/candidiasis-therapeutics-market

License

Buy Now

Summary ToC Companies

Key Players

Astellas Pharma Inc
BristolMyers Squibb Company
Cadila Healthcare Limited
Cipla Ltd
GSK
HoffmannLa Roche Ltd
The Vanguard Group
Merck KGaA
Mylan N.V
Novartis
Shionogi & Co. Ltd
Sun Pharmaceutical Industries Ltd
Berkshire Hathaway

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Candidiasis Therapeutics Market

Key Players

Similar Industry Reports